Today, we approved the first gene therapy for the treatment of patients 4-5 years of age with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who do not have a pre-existing medical reason why they can't receive this therapy. https://t.co/AA02wAusjK
Congratulations to Dawn Lowe, PhD, and Antoinette Moran, MD, for receiving the 2023 Carole J. Bland Award for Outstanding Faculty Mentorship for being exceptional mentors to other U of M faculty.🏆 Read more: https://t.co/zwvMP4T2yu.
To every researcher entrenched in or just curious about circadian biology: register now for our Cincinnati Circadian Conference (C3) on September 1st, 2023 at https://t.co/d5LbpmnAdn
- free registration (in-person only)
- abstract submission
- great for networking
Please RT!
@MegJane12@BarefieldD For the first one I’ve run in 2 years it was (fortunately) extremely uneventful…but I was able to replicate old data so I’ll consider it a win!
The first experiment after officially starting my PhD is about to be a western blot…& historically speaking this could either be a very good or a very bad sign…Stay tuned
An antibody therapy from Demonbreun, @emmcnally, and co can protect muscle function and respiration from the degenerative effects of #MuscularDystrophy in mice, either alone or in combination with the standard drug #prednisone. https://t.co/qz29pA4Jk2 @NorthwesternU
Virtual MD/PhD Info Session on Mon June 28 at 7 PM CDT. Info/Q&A about MD/PhD training, @UMNMSTP & admissions with @YojiShimizu, @Kate_Fallon_, @mikejmander, Liz O. Register at https://t.co/ePL5EjwZwJ